Sick building syndrome (SBS) happens when people feel unwell in a specific building, usually due to factors like poor air quality or inadequate ventilation. Common symptoms include headaches, fatigue, ...

That's why two girls with the same mutated gene might have very different symptoms. Two other genes, CDKL5 and FOXG1, are associated with variations of RTT. Although Rett syndrome is genetic ...

Acute kidney injury is a significant complication among patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome, occurring in 25% of cases and often associated with disease ...

Roemheld syndrome (RS), also known as Roemheld-Techlenburg-Ceconi-Syndrome or gastric-cardia, is a complex of gastrocardiac symptoms first described by Ludwig von Roemheld (1871–1938). Roemheld ...

Birt-Hogg-Dubé syndrome (BHDS) is a rare genetic skin ... This article examines BHDS, describing its symptoms, causes, and treatments. It also explains how doctors diagnose BHDS and answers ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that the ...

A systematic literature search for clinical reports and reviews published between 2000 and 2008 was undertaken using Pub Med and the Cochrane databases. Search words were "HELLP syndrome", and ...

SLE patients (n = 3389) who had undergone hysterectomy were less likely to develop nephritis or positive anti-double-strand DNA antibodies than age-matched SLE patients who had not (odds ratio ...

July 10, 2024 — Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect ...

Symptoms of thyroid disease in males can include effects not seen in females. Erectile dysfunction (ED) and male breast enlargement, for example, are associated with thyroid dysfunction but otherwise ...

Objective Randomised trials of type I anti-CD20 antibodies rituximab and ocrelizumab failed to show benefit in proliferative lupus nephritis (LN). We compared obinutuzumab, a humanised type II ...